Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Viracta Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 40K | Jun 9, 2022 | Direct | ||
Bolt Biotherapeutics, Inc. | Director | Stock Option (Right to Buy) | 22K | Jun 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
BOLT | Bolt Biotherapeutics, Inc. | Jun 12, 2024 | 1 | $0 | 4 | Jun 14, 2024 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Jun 12, 2023 | 1 | $0 | 4 | Jun 14, 2023 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Jun 10, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
VIRX | Viracta Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Mar 24, 2022 | 2 | $0 | 4 | Mar 28, 2022 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Dec 14, 2021 | 1 | $0 | 4 | Dec 16, 2021 | Director |
BOLT | Bolt Biotherapeutics, Inc. | Dec 14, 2021 | 0 | $0 | 3 | Dec 16, 2021 | Director |